[CEA--a parameter in the course of chemotherapy of ovarian cancer].
D002272:Carcinoembryonic Antigen / Q000032:analysis*; D003520:Cyclophosphamide / Q000627:therapeutic use; D004317:Doxorubicin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis; D010051:Ovarian Neoplasms / Q000188:drug therapy*
D002272:Carcinoembryonic Antigen; D004317:Doxorubicin; D003520:Cyclophosphamide
CEA--Ein Verlaufsparameter bei der Chemotherapie des Ovarialkarzinoms.